SC

Sui Xiong Cai

CY Cytovia: 45 patents #1 of 42Top 3%
CI Cocensys, Incorporated: 13 patents #1 of 27Top 4%
SO State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon: 12 patents #3 of 13Top 25%
ES Euro-Celtique S.A.: 11 patents #13 of 215Top 7%
University of California: 10 patents #600 of 18,278Top 4%
WC Warner-Lambert Company: 7 patents #219 of 1,610Top 15%
AP Acea Pharmaceuticals: 5 patents #1 of 6Top 20%
IT Impact Therapeutics: 5 patents #2 of 27Top 8%
SB Shire Biochem: 3 patents #1 of 38Top 3%
MY Myrexis: 3 patents #2 of 44Top 5%
UO University Of Oregon: 3 patents #21 of 113Top 20%
SU State Of Oregon, Acting By And Through The Oregon State Board Of Higer Education, Acting For And On Behalf Of The Oregon Health Sciences University: 1 patents #7 of 13Top 55%
UO University Of Oregon: 1 patents #47 of 170Top 30%
EP Epicept: 1 patents #6 of 17Top 40%
Overall (All Time): #16,854 of 4,157,543Top 1%
93
Patents All Time

Issued Patents All Time

Showing 76–93 of 93 patents

Patent #TitleCo-InventorsDate
6130234 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists Christopher Franklin Bigge, Jonathan Wright, Eckard Weber, Richard Woodward, Nancy C. Lan +2 more 2000-10-10
6124317 2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists Christopher Franklin Bigge, John F. W. Keana, Eckard Weber, Richard Woodward, Nancy C. Lan +1 more 2000-09-26
6124323 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists Christopher Franklin Bigge, Po-Wai Yuen, Eckard Weber, Richard Woodward, Nancy C. Lan +3 more 2000-09-26
5977107 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists Eckard Weber, John F. W. Keana, Sunil Kher 1999-11-02
5891871 Substituted 2,3-benzodiazepin-4-ones and the use thereof Haiji Xia, George F. Field, Nancy C. Lan, Yan Wang 1999-04-06
5863916 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor John F. W. Keana, Eckard Weber 1999-01-26
5801183 Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists John F. W. Keana, Zhang-Lin Zhou, James M. Navratil 1998-09-01
5708168 Azepine compounds John F. W. Keana, Anthony P. Guzikowski, Daniel F. Nogales 1998-01-13
5652368 1,2,3,4-tetrahydroquinoline 2,3,4-trione-3 or 4-oximes John F. W. Keana, Eckard Weber 1997-07-29
5631373 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones Eckard Weber, John F. W. Keana, Sunil Kher 1997-05-20
5622965 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists Eckard Weber, John F. W. Keana 1997-04-22
5620978 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor John F. W. Keana, Eckard Weber 1997-04-15
5597922 Glycine receptor antagonist pharmacophore John F. W. Keana, Eckard Weber 1997-01-28
5582955 Chemical functionalization of surfaces John F. W. Keana, Martin N. Wybourne, Mingdi Yan 1996-12-10
5580697 Chemical functionalization of surfaces John F. W. Keana, Martin N. Wybourne, Mingdi Yan 1996-12-03
5476933 Azepine synthesis via a diels-alder reaction John F. W. Keana, Anthony P. Guzikowski, Daniel F. Nogales 1995-12-19
5475007 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and the use thereof John F. W. Keana, Eckard Weber 1995-12-12
5465151 Sensors employing interference of electromagnetic waves passing through waveguides having functionalized surfaces Martin N. Wybourne, John F. W. Keana, Mingdi Yan, Jong-Ching Wu 1995-11-07